SOLIGENIX, INC.: Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease
Study DUS-AUBD-01 opens patient enrollment PRINCETON, N.J., Nov. 14, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage ...
Neupath Health Reports Third Quarter 2024 Results
NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced ...
Seeking Alpha11h
3 High Yield October Dividend Payers: Blackstone, Ready Capital And Medical Property Trust
That article was mostly positive and meant not to cover the 3 cuts, as they are the hardest to report, evaluate and sadly I ...
The Globe and Mail19h
Quipt Home Medical: Top 10 Undervalued Healthcare Sector Stocks on TSX (QIPT)
Quipt Home Medical is now ranked among the top 10 undervalued stocks in the Healthcare sector on the Toronto Stock Exchange. A stock is considered undervalued if it trades at a discount to its ...
Becker's Hospital Review1d
AMA considers MyChart billing resolution: 5 things to know
Learn about the American Medical Association's consideration of a resolution to bill patients for MyChart messages and the potential effects on healthcare.
High Tide: Top 10 Undervalued Healthcare Providers & Services Industry Stocks (HITI)
High Tide is now ranked among the top 10 undervalued stocks in the Healthcare Providers & Services industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if ...
Sticks, stars, sickness: How early charts plotted the way we were
From dots and dashes on cave walls to maps of ocean tides and then the earliest graphs, see how we’ve been visualising data ...